SearchFrank Wilson
Frank Wilson was founding chair of then TFS group, having been appointed on 28 March 2000. In December 2006 he was appointed executive chair, a role which he held until 10 November 2011 when he resigned from the board. On 12 June 2012, he was re-appointed to the board as an executive director. In March 2017, following TFS' rebrand to Quintis and attacks on Quintis' credibility by activist shortseller Glaucus Research, Mr Wilson resigned as managing director to take up a role at a then undisclosed company intending a potential takeover of Quintis. He was previously the managing partner of legal firm Wilson & Atkinson which specialises in taxation, property and commercial law.
Bio last updated 08 Jul 2019
Article Timeline
Positions - Previous
| Position | Company | Year | Company's current rank | WA staff |
|---|---|---|---|---|
| Founder, Managing Director | | 1997 - 2017 | 23 | |
| Founder | | 1991 - 2007 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| Quintis | 23 Mar 2017 | Bought | 50,000 | $1.19 | $59,250 | On-market trade |
| Quintis | 19 Dec 2016 | Issued | 242,577 | OtherIssue of securities: 1,005,837 - Performance rights. | ||
| Quintis | 05 May 2016 | Bought | 5,618 | $1.55 | $8,708 | OtherParticipation in share purchase plan |
| Quintis | 02 Mar 2016 | Bought | 836,000 | $1.73 | $1,449,669 | On-market trade |
| Quintis | 22 Jan 2016 | Issued | 250,593 | OtherIssue of securities: 763260-performance rights |
Source: Morningstar
Equity Capital Markets Deals
| Date | Company | Transaction Type | Total Value | |
|---|---|---|---|---|
| 07/04/16 | Quintis | Placement + share purchase plan | $68.5m | >> |
| 08/07/14 | Quintis | Placement | $67.0m | >> |
| 02/02/12 | Quintis | Placement | $37.9m | >> |
| 06/05/16 | Quintis | Other | $9.6m | >> |
Mergers & Acquisitions Deals
| Announced | Bidder | Target | Transaction Type | Total Value | |
|---|---|---|---|---|---|
| 01/07/14 | Quintis | Asset acquisition | $35.0m | >> | |
| 18/06/15 | Quintis | Santalis Pharmaceuticals, ViroXis Corporation | Acquisition | $30.3m | >> |
| 13/11/15 | Quintis | TFS Properties | Asset acquisition | $13.0m | >> |
| 20/12/13 | Quintis | Bonalbo Cattle Company | Asset acquisition | $8.5m | >> |
| 20/01/12 | Quintis | Asset acquisition | $4.5m | >> |
Share Transactions
BNiQ Disclaimer
Some of the information on ASX-listed public companies is sourced from Morningstar Australasia Pty Ltd (ABN: 95 090 665 544).
It is important to note that the Morningstar information displayed by Business News is not to be copied or distributed except as authorised; and that such information is not warranted to be accurate, complete or timely and that neither Morningstar nor Business News are responsible for any damages or losses arising from any use of this information.
The information is general information only and does not constitute financial advice It is not intended to be, and should not be construed in any way as, investment, legal or financial advice
Retail clients should be advised the Morningstar Financial Services Guide can be found at http://www.morningstar.com.au/fsg.asp
Show moreIt is important to note that the Morningstar information displayed by Business News is not to be copied or distributed except as authorised; and that such information is not warranted to be accurate, complete or timely and that neither Morningstar nor Business News are responsible for any damages or losses arising from any use of this information.
The information is general information only and does not constitute financial advice It is not intended to be, and should not be construed in any way as, investment, legal or financial advice
Retail clients should be advised the Morningstar Financial Services Guide can be found at http://www.morningstar.com.au/fsg.asp
